Aurora Cannabis (ACB) EBIT Growth (3y) (2020 - 2025)
Aurora Cannabis (ACB) EBIT Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Aurora Cannabis | 233.45 Mn | 161.14 Mn | 25.75 Mn | -20.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.23% |
| Sep 30, 2025 | 26.71% |
| Jun 30, 2025 | 71.54% |
| Mar 31, 2025 | 33.58% |
| Dec 31, 2024 | 37.44% |
| Sep 30, 2024 | 61.73% |
| Jun 30, 2024 | 74.06% |
| Mar 31, 2024 | 75.42% |
| Dec 31, 2023 | 28.98% |
| Sep 30, 2023 | 36.65% |
| Jun 30, 2023 | -106.79% |
| Dec 31, 2022 | -50.75% |
| Sep 30, 2022 | -50.63% |
| Jun 30, 2022 | 52.49% |
| Mar 31, 2022 | -43.89% |
| Dec 31, 2021 | -39.74% |
| Sep 30, 2021 | -33.24% |
| Jun 30, 2021 | -3.77% |
| Mar 31, 2021 | -66.59% |
| Dec 31, 2020 | -41.86% |